Hem › Multipel skleros › Florida
Kliniska studier för Multipel skleros i Florida
14 studier för Multipel skleros söker deltagare vid platser i Florida.
Städer i Florida
Officiell studietext (engelska)
A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
- Aqualane Clinical Research, Naples
- USF Health, Tampa
RekryterarFas 2
Ålder 18 till 70 · Alla kön · Uppdaterad 1 okt. 2026 · NCT06782490A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy
- Neurology Associates, PA, Maitland
RekryterarFas 4
Ålder 18 till 65 · Alla kön · Uppdaterad 30 sep. 2026 · NCT07609719A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
- TG Therapeutics Investigational Trial Site, Altamonte Springs
- TG Therapeutics Investigational Trial Site, Boca Raton
- TG Therapeutics Investigational Trial Site, Clearwater
- och 7 fler
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 23 sep. 2026 · NCT06433752Clinical Applications of Advanced Ophthalmic Imaging
- Bascom Palmer Eye Institute, Miami
RekryterarFriska volontärer välkomna
Ålder 18 till 99 · Alla kön · Uppdaterad 16 sep. 2026 · NCT03135327RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- University of South Florida, Department of Psychiatry and Behavioral Neuroscience, Tampa
RekryterarFas 2
Ålder 18 till 80 · Alla kön · Uppdaterad 15 sep. 2026 · NCT07002034Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
- Neurology of Central Florida- Site Number : 8400147, Altamonte Springs
- Aqualane Clinical Research- Site Number : 8400026, Naples
- Neurology Associates of Ormond Beach- Site Number : 8400086, Ormond Beach
- och 1 fler
RekryterarFas 3
Ålder 18 till 60 · Alla kön · Uppdaterad 15 sep. 2026 · NCT07325292Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
- University of South Florida, Tampa
RekryterarFas 3
Ålder 10 till 17 · Alla kön · Uppdaterad 10 sep. 2026 · NCT06408259A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- Neurology of Central FL Res Ctr, Altamonte Springs
- UF Health Cancer Center, Gainesville
- Homestead Assoc In Research Inc, Homestead
- och 8 fler
RekryterarFas 3
Ålder 18 till 65 · Alla kön · Uppdaterad 29 juli 2026 · NCT07225504Neurologic Stem Cell Treatment Study
- MD Stem Cells, Coral Springs
Rekryterar
Ålder 18 och äldre · Alla kön · Uppdaterad 26 juni 2026 · NCT02795052Dry Needling in Multiple Sclerosis
- University of South Florida, Tampa
Rekryterar
Ålder 18 till 80 · Alla kön · Uppdaterad 29 maj 2026 · NCT07615725Wearable Focal Vibration Therapy on Upper Extremity Function of People With Multiple Sclerosis: A Pilot Study
- Norman Fixel Institute for Neurological Diseases, Gainesville
- University of Florida, Gainesville
Rekryterar
Ålder 18 till 100 · Alla kön · Uppdaterad 6 mars 2026 · NCT07376772Effects of Torso Weighting on Muscle Activation During Balance Tests in Individuals With and Without Multiple Sclerosis
- University of St. Augustine for Health Sciences, Saint Augustine
RekryterarFriska volontärer välkomna
Ålder 18 till 75 · Alla kön · Uppdaterad 20 maj 2025 · NCT06981013Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers
- Mayo Clinic Jacksonville, Jacksonville
RekryterarFas 1/2Friska volontärer välkomna
Ålder 18 till 80 · Alla kön · Uppdaterad 2 maj 2025 · NCT05395624Longitudinal Cognitive Assessment by BoCA
- Andrey Vyshedskiy, Miami
RekryterarObservationsstudieFriska volontärer välkomna
Ålder 50 och äldre · Alla kön · Uppdaterad 1 aug. 2024 · NCT04114994Från ClinicalTrials.gov, data hämtad 3 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.